Literature DB >> 28440313

Regulation is no bad thing.

Emma H Wilson1.   

Abstract

Year:  2017        PMID： 28440313     DOI： 10.1038/icb.2017.19

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN： 0818-9641            Impact factor:   5.126


× No keyword cloud information.
  13 in total

1.  Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.

Authors:  Jürgen Haas; Andreas Hug; Andrea Viehöver; Benedikt Fritzsching; Christine S Falk; Andrea Filser; Tina Vetter; Linda Milkova; Mirjam Korporal; Brigitte Fritz; Brigitte Storch-Hagenlocher; Peter H Krammer; Elisabeth Suri-Payer; Brigitte Wildemann
Journal:  Eur J Immunol       Date:  2005-11       Impact factor: 5.532

2.  Central inflammation versus peripheral regulation in multiple sclerosis.

Authors:  L J Edwards; B Sharrack; A Ismail; H Tumani; C S Constantinescu
Journal:  J Neurol       Date:  2011-03-09       Impact factor: 4.849

3.  Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells.

Authors:  Daniel R Getts; Danielle M Turley; Cassandra E Smith; Christopher T Harp; Derrick McCarthy; Emma M Feeney; Meghann Teague Getts; Aaron J Martin; Xunrong Luo; Rachael L Terry; Nicholas J C King; Stephen D Miller
Journal:  J Immunol       Date:  2011-08-05       Impact factor: 5.422

4.  Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis.

Authors:  Andreas Lutterotti; Sara Yousef; Andreas Sputtek; Klarissa H Stürner; Jan-Patrick Stellmann; Petra Breiden; Stefanie Reinhardt; Christian Schulze; Maxim Bester; Christoph Heesen; Sven Schippling; Stephen D Miller; Mireia Sospedra; Roland Martin
Journal:  Sci Transl Med       Date:  2013-06-05       Impact factor: 17.956

5.  Identification of IL-17-producing FOXP3+ regulatory T cells in humans.

Authors:  Kui Shin Voo; Yui-Hsi Wang; Fabio R Santori; Cesar Boggiano; Yi-Hong Wang; Kazuhiko Arima; Laura Bover; Shino Hanabuchi; Jahan Khalili; Ekaterina Marinova; Biao Zheng; Dan R Littman; Yong-Jun Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-09       Impact factor: 11.205

6.  The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+ regulatory T cells.

Authors:  Richard A O'Connor; Katy H Malpass; Stephen M Anderton
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

7.  The alarmin IL-33 promotes regulatory T-cell function in the intestine.

Authors:  Chris Schiering; Thomas Krausgruber; Agnieszka Chomka; Anja Fröhlich; Krista Adelmann; Elizabeth A Wohlfert; Johanna Pott; Thibault Griseri; Julia Bollrath; Ahmed N Hegazy; Oliver J Harrison; Benjamin M J Owens; Max Löhning; Yasmine Belkaid; Padraic G Fallon; Fiona Powrie
Journal:  Nature       Date:  2014-07-16       Impact factor: 49.962

8.  Distinct T cell signatures define subsets of patients with multiple sclerosis.

Authors:  Mark C Johnson; Emily R Pierson; Andrew J Spieker; A Scott Nielsen; Sylvia Posso; Mariko Kita; Jane H Buckner; Joan M Goverman
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-08-23

9.  M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination.

Authors:  Robin J M Franklin; Charles Ffrench-Constant; Veronique E Miron; Amanda Boyd; Jing-Wei Zhao; Tracy J Yuen; Julia M Ruckh; Jennifer L Shadrach; Peter van Wijngaarden; Amy J Wagers; Anna Williams
Journal:  Nat Neurosci       Date:  2013-07-21       Impact factor: 24.884

10.  Role of IL-33 and ST2 signalling pathway in multiple sclerosis: expression by oligodendrocytes and inhibition of myelination in central nervous system.

Authors:  Debbie Allan; Karen J Fairlie-Clarke; Christina Elliott; Cornelia Schuh; Susan C Barnett; Hans Lassmann; Christopher Linnington; Hui-Rong Jiang
Journal:  Acta Neuropathol Commun       Date:  2016-07-26       Impact factor: 7.801
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.